pI: 6.2449 |
Length (AA): 925 |
MW (Da): 99076 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
70 | 737 | 1z3i (X) | 95 | 735 | 22.00 | 0 | 1 | 0.64 | 0.03 |
468 | 629 | 1t5i (A) | 261 | 415 | 15.00 | 0.0000000011 | 0.36 | 0.43 | -1.3 |
114 | 613 | 5jxr (A) | 179 | 624 | 34.00 | 0 | 1 | 0.777541 | 0.35 |
115 | 711 | 1z3i (X) | 141 | 698 | 29.00 | 0 | 1 | 0.831405 | 0.46 |
483 | 622 | 3ews (B) | 320 | 459 | 19.00 | 0 | 0.5 | 0.397851 | -0.68 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_131776)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G63950 | protein chromatin remodeling 24 |
Cryptosporidium hominis | Chro.50081 | hypothetical protein |
Cryptosporidium parvum | cgd5_2920 | hypothetical protein |
Dictyostelium discoideum | DDB_G0288873 | CHR group protein |
Echinococcus granulosus | EgrG_000704200 | DNA excision repair protein ERCC 6 |
Entamoeba histolytica | EHI_103660 | helicase, putative |
Echinococcus multilocularis | EmuJ_000704200 | DNA excision repair protein ERCC 6 |
Homo sapiens | ENSG00000186871 | excision repair cross-complementation group 6-like |
Leishmania braziliensis | LbrM.01.0280 | DNA excision/repair protein SNF2, putative |
Leishmania donovani | LdBPK_010240.1 | DNA excision/repair protein SNF2, putative |
Leishmania infantum | LinJ.01.0240 | DNA excision/repair protein SNF2, putative |
Leishmania major | LmjF.01.0240 | DNA excision/repair protein SNF2, putative |
Leishmania mexicana | LmxM.01.0240 | DNA excision/repair protein SNF2, putative |
Mus musculus | 236930 | excision repair cross-complementing rodent repair deficiency complementation group 6 like |
Oryza sativa | 9270485 | Os10g0565700 |
Oryza sativa | 4337517 | Os04g0692700 |
Oryza sativa | 9266414 | Os04g0692750 |
Schistosoma japonicum | Sjp_0042810 | DNA excision repair protein ERCC-6-like, putative |
Schistosoma mansoni | Smp_166940 | excision repair helicase ercc-6-related |
Schmidtea mediterranea | mk4.004959.00 | DNA excision repair protein ERCC-6-like |
Trypanosoma cruzi | TcCLB.511577.60 | DNA excision/repair protein SNF2, putative |
Trypanosoma cruzi | TcCLB.504797.70 | DNA excision/repair protein SNF2, putative |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.